MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).
Novo Nordisk announced that the FDA has approved NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] injection) FlexTouch, its two new prefilled ...
PLAINSBORO, N.J., Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) has approved the prefilled insulin pens ...
PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir ® FlexTouch ® ...
Novo Nordisk said it will continue providing Levemir vials and the Levemir FlexPen for diabetes control while supplies last, until the full product discontinuation at the end of 2024. Novo Nordisk has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback